secwatch.observer — SEC 8-K summary
======================================

Issuer:     Alaunos Therapeutics, Inc. (TCRT)
CIK:        0001107421
Form:       8-K
Filed at:   2025-06-26T23:59:59+00:00
Accession:  0000950170-25-090202
Event type: other_material
Sentiment:  neutral
Materiality: 0.60
Item codes: 1.01, 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Alaunos Therapeutics raises ~$2.05M in registered direct offering of stock and pre-funded warrants
--------------------------------------------------------------------------------

- 338,725 shares at $3.36; 271,674 pre-funded warrants at $3.359/share.
- Total gross proceeds ~$2.05M; offering closed June 24, 2025.
- Net proceeds for general corporate purposes, including working capital and capex.
- Offered under effective shelf registration statement (File No. 333-266841).
- Pre-funded warrants have $0.001 exercise price; 4.99% or 9.99% beneficial ownership limit.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1107421/000095017025090202/0000950170-25-090202-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1107421/000095017025090202/tcrt-20250620.htm
  HTML page:      https://secwatch.observer/filing/0000950170-25-090202

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer